Doubtful but wishful. Decent news but not a big needle mover imo. Good progress moving towards IDE submission. With a FDA meeting schedule for “sometime this year “ to go over interim results, my guess is IDE submission won’t be until Q4 or Q1 next year. That is when this moves 10x imo. Until then this continues in the 03/04 range with some expected dips from lack of further news.